Annual Operating Profit
-$52.36 M
-$9.75 M-22.90%
31 December 2023
Summary:
Aptose Biosciences annual operaing income is currently -$52.36 million, with the most recent change of -$9.75 million (-22.90%) on 31 December 2023. During the last 3 years, it has risen by +$3.41 million (+6.12%). APTO annual operating profit is now -502.47% below its all-time high of $13.01 million, reached on 31 May 2003.APTO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$6.96 M
+$380.00 K+5.17%
30 September 2024
Summary:
Aptose Biosciences quarterly operating income is currently -$6.96 million, with the most recent change of +$380.00 thousand (+5.17%) on 30 September 2024. Over the past year, it has increased by +$4.72 million (+40.37%). APTO quarterly operating profit is now -258.65% below its all-time high of $4.39 million, reached on 31 May 2003.APTO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$36.20 M
+$4.72 M+11.53%
30 September 2024
Summary:
Aptose Biosciences TTM operating income is currently -$36.20 million, with the most recent change of +$4.72 million (+11.53%) on 30 September 2024. Over the past year, it has increased by +$14.44 million (+28.51%). APTO TTM operating profit is now -2458.11% below its all-time high of $1.53 million, reached on 31 May 2003.APTO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APTO Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.9% | +40.4% | +28.5% |
| 3 y3 years | +6.1% | +38.7% | +35.2% |
| 5 y5 years | -79.9% | +0.9% | -43.1% |
APTO Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -22.9% | +20.0% | at high | +71.4% | at high | +44.7% |
| 5 y | 5 years | -94.9% | +20.0% | at high | +71.4% | -43.1% | +44.7% |
| alltime | all time | -502.5% | +20.0% | -258.6% | +71.4% | -2458.1% | +44.7% |
Aptose Biosciences Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$6.96 M(-5.2%) | -$36.20 M(-11.5%) |
| June 2024 | - | -$7.34 M(-24.7%) | -$40.91 M(-14.8%) |
| Mar 2024 | - | -$9.76 M(-19.5%) | -$48.02 M(-8.3%) |
| Dec 2023 | -$52.36 M(+22.9%) | -$12.13 M(+3.8%) | -$52.36 M(+3.4%) |
| Sept 2023 | - | -$11.68 M(-19.2%) | -$50.63 M(+3.4%) |
| June 2023 | - | -$14.45 M(+2.5%) | -$48.98 M(+8.4%) |
| Mar 2023 | - | -$14.10 M(+35.5%) | -$45.20 M(+6.1%) |
| Dec 2022 | -$42.60 M(-34.9%) | -$10.40 M(+3.8%) | -$42.60 M(-24.7%) |
| Sept 2022 | - | -$10.03 M(-6.1%) | -$56.55 M(-2.3%) |
| June 2022 | - | -$10.67 M(-7.2%) | -$57.88 M(-4.6%) |
| Mar 2022 | - | -$11.50 M(-52.8%) | -$60.70 M(-7.3%) |
| Dec 2021 | -$65.45 M(+17.4%) | -$24.35 M(+114.3%) | -$65.45 M(+17.2%) |
| Sept 2021 | - | -$11.36 M(-15.8%) | -$55.86 M(-3.3%) |
| June 2021 | - | -$13.49 M(-17.0%) | -$57.79 M(-4.0%) |
| Mar 2021 | - | -$16.25 M(+10.1%) | -$60.19 M(+7.9%) |
| Dec 2020 | -$55.77 M(+107.6%) | -$14.76 M(+11.0%) | -$55.77 M(+14.1%) |
| Sept 2020 | - | -$13.29 M(-16.3%) | -$48.89 M(+14.7%) |
| June 2020 | - | -$15.88 M(+34.2%) | -$42.63 M(+28.8%) |
| Mar 2020 | - | -$11.83 M(+50.1%) | -$33.09 M(+23.2%) |
| Dec 2019 | -$26.86 M(-7.7%) | -$7.88 M(+12.2%) | -$26.86 M(+6.2%) |
| Sept 2019 | - | -$7.03 M(+10.7%) | -$25.30 M(+5.9%) |
| June 2019 | - | -$6.35 M(+13.3%) | -$23.88 M(-14.3%) |
| Mar 2019 | - | -$5.60 M(-11.5%) | -$27.86 M(-4.3%) |
| Dec 2018 | -$29.11 M(+146.1%) | -$6.33 M(+12.7%) | -$29.11 M(+11.6%) |
| Sept 2018 | - | -$5.61 M(-45.7%) | -$26.09 M(+12.5%) |
| June 2018 | - | -$10.33 M(+51.0%) | -$23.19 M(+51.2%) |
| Mar 2018 | - | -$6.84 M(+106.6%) | -$15.34 M(+29.7%) |
| Dec 2017 | -$11.83 M(-17.1%) | -$3.31 M(+22.2%) | -$11.83 M(+1.6%) |
| Sept 2017 | - | -$2.71 M(+9.2%) | -$11.64 M(-3.4%) |
| June 2017 | - | -$2.48 M(-25.4%) | -$12.05 M(-13.5%) |
| Mar 2017 | - | -$3.33 M(+6.4%) | -$13.92 M(-3.2%) |
| Dec 2016 | -$14.27 M(+11.0%) | -$3.13 M(+0.4%) | -$14.39 M(-7.9%) |
| Sept 2016 | - | -$3.12 M(-28.5%) | -$15.63 M(+1.0%) |
| June 2016 | - | -$4.36 M(+14.9%) | -$15.48 M(+9.1%) |
| Mar 2016 | - | -$3.79 M(-13.2%) | -$14.19 M(+6.9%) |
| Dec 2015 | -$12.86 M(+87.8%) | -$4.37 M(+47.7%) | -$13.28 M(+49.0%) |
| Sept 2015 | - | -$2.96 M(-3.7%) | -$8.91 M(+49.7%) |
| June 2015 | - | -$3.07 M(+6.6%) | -$5.95 M(-1.7%) |
| Mar 2015 | - | -$2.88 M(-9.2%) | -$6.05 M(-31.8%) |
| Dec 2014 | -$6.84 M(-22.4%) | - | - |
| May 2014 | -$8.82 M(+62.6%) | -$3.17 M(+49.1%) | -$8.88 M(+27.6%) |
| Feb 2014 | - | -$2.13 M(-17.2%) | -$6.96 M(+12.6%) |
| Nov 2013 | - | -$2.57 M(+154.2%) | -$6.18 M(+17.8%) |
| Aug 2013 | - | -$1.01 M(-19.3%) | -$5.25 M(-4.7%) |
| May 2013 | -$5.42 M(+21.5%) | -$1.25 M(-7.1%) | -$5.51 M(+8.1%) |
| Feb 2013 | - | -$1.35 M(-17.5%) | -$5.09 M(+6.7%) |
| Nov 2012 | - | -$1.63 M(+28.6%) | -$4.77 M(+4.9%) |
| Aug 2012 | - | -$1.27 M(+51.6%) | -$4.55 M(+2.8%) |
| May 2012 | -$4.46 M(-11.7%) | -$839.00 K(-18.4%) | -$4.43 M(-5.8%) |
| Feb 2012 | - | -$1.03 M(-27.2%) | -$4.70 M(-10.6%) |
| Nov 2011 | - | -$1.41 M(+23.3%) | -$5.25 M(+5.2%) |
| Aug 2011 | - | -$1.15 M(+3.0%) | -$5.00 M(+1.6%) |
| May 2011 | -$5.05 M | -$1.11 M(-29.7%) | -$4.92 M(-12.7%) |
| Feb 2011 | - | -$1.58 M(+37.1%) | -$5.63 M(+5.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2010 | - | -$1.15 M(+8.1%) | -$5.33 M(-0.6%) |
| Aug 2010 | - | -$1.07 M(-41.6%) | -$5.36 M(+0.3%) |
| May 2010 | -$5.39 M(-17.9%) | -$1.83 M(+42.8%) | -$5.34 M(-2.1%) |
| Feb 2010 | - | -$1.28 M(+7.8%) | -$5.46 M(-4.7%) |
| Nov 2009 | - | -$1.19 M(+13.0%) | -$5.73 M(-3.9%) |
| Aug 2009 | - | -$1.05 M(-46.0%) | -$5.96 M(-14.0%) |
| May 2009 | -$6.57 M(-40.4%) | -$1.94 M(+25.4%) | -$6.94 M(-15.2%) |
| Feb 2009 | - | -$1.55 M(+9.1%) | -$8.18 M(-18.9%) |
| Nov 2008 | - | -$1.42 M(-29.9%) | -$10.08 M(-11.0%) |
| Aug 2008 | - | -$2.02 M(-36.4%) | -$11.33 M(+3.7%) |
| May 2008 | -$11.03 M(+44.7%) | -$3.18 M(-7.7%) | -$10.92 M(+14.8%) |
| Feb 2008 | - | -$3.45 M(+29.2%) | -$9.51 M(+26.5%) |
| Nov 2007 | - | -$2.67 M(+65.3%) | -$7.52 M(+3.1%) |
| Aug 2007 | - | -$1.61 M(-9.2%) | -$7.29 M(-6.6%) |
| May 2007 | -$7.63 M(-49.5%) | -$1.78 M(+22.2%) | -$7.81 M(-11.1%) |
| Feb 2007 | - | -$1.46 M(-40.4%) | -$8.78 M(-17.3%) |
| Nov 2006 | - | -$2.44 M(+14.6%) | -$10.62 M(-13.6%) |
| Aug 2006 | - | -$2.13 M(-22.6%) | -$12.30 M(-16.8%) |
| May 2006 | -$15.09 M(-13.4%) | -$2.75 M(-16.6%) | -$14.78 M(-3.0%) |
| Feb 2006 | - | -$3.30 M(-19.9%) | -$15.24 M(-5.5%) |
| Nov 2005 | - | -$4.12 M(-10.7%) | -$16.12 M(-5.4%) |
| Aug 2005 | - | -$4.61 M(+43.4%) | -$17.04 M(-1.5%) |
| May 2005 | -$17.42 M(-24.7%) | -$3.21 M(-23.1%) | -$17.30 M(-12.4%) |
| Feb 2005 | - | -$4.18 M(-17.0%) | -$19.75 M(-9.9%) |
| Nov 2004 | - | -$5.04 M(+3.5%) | -$21.91 M(+0.8%) |
| Aug 2004 | - | -$4.87 M(-14.1%) | -$21.73 M(-5.7%) |
| May 2004 | -$23.15 M(-278.0%) | -$5.66 M(-10.7%) | -$23.05 M(+77.3%) |
| Feb 2004 | - | -$6.34 M(+30.4%) | -$13.00 M(+231.4%) |
| Nov 2003 | - | -$4.86 M(-21.4%) | -$3.92 M(+118.2%) |
| Aug 2003 | - | -$6.19 M(-240.9%) | -$1.80 M(-217.1%) |
| May 2003 | $13.01 M(-228.4%) | $4.39 M(+60.4%) | $1.53 M(-126.2%) |
| Feb 2003 | - | $2.74 M(-200.0%) | -$5.85 M(-45.8%) |
| Nov 2002 | - | -$2.74 M(-4.1%) | -$10.79 M(+0.4%) |
| Aug 2002 | - | -$2.85 M(-4.6%) | -$10.75 M(+4.8%) |
| May 2002 | -$10.13 M(-14.0%) | -$2.99 M(+35.5%) | -$10.26 M(-12.5%) |
| Feb 2002 | - | -$2.21 M(-18.1%) | -$11.72 M(-0.2%) |
| Nov 2001 | - | -$2.70 M(+14.3%) | -$11.74 M(-2.2%) |
| Aug 2001 | - | -$2.36 M(-47.0%) | -$12.00 M(+1.1%) |
| May 2001 | -$11.78 M(+93.1%) | -$4.45 M(+100.0%) | -$11.87 M(+7.5%) |
| Feb 2001 | - | -$2.23 M(-24.9%) | -$11.04 M(+10.6%) |
| Nov 2000 | - | -$2.96 M(+32.9%) | -$9.99 M(+29.7%) |
| Aug 2000 | - | -$2.23 M(-38.4%) | -$7.70 M(+32.7%) |
| May 2000 | -$6.10 M(+83.6%) | -$3.62 M(+209.0%) | -$5.80 M(+94.2%) |
| Feb 2000 | - | -$1.17 M(+72.5%) | -$2.99 M(+14.4%) |
| Nov 1999 | - | -$679.10 K(+103.0%) | -$2.61 M(+1.1%) |
| Aug 1999 | - | -$334.50 K(-58.4%) | -$2.58 M(-17.6%) |
| May 1999 | -$3.32 M(-1.2%) | -$803.40 K(+1.0%) | -$3.14 M(-3.1%) |
| Feb 1999 | - | -$795.50 K(+22.2%) | -$3.24 M(+0.7%) |
| Nov 1998 | - | -$651.00 K(-26.5%) | -$3.21 M(-3.7%) |
| Aug 1998 | - | -$885.90 K(-2.1%) | -$3.34 M(+5.2%) |
| May 1998 | -$3.36 M(-3.4%) | -$904.80 K(+17.1%) | -$3.17 M(+39.9%) |
| Feb 1998 | - | -$772.90 K(-0.0%) | -$2.27 M(+51.8%) |
| Nov 1997 | - | -$773.00 K(+7.4%) | -$1.49 M(+107.4%) |
| Aug 1997 | - | -$719.90 K | -$719.90 K |
| May 1997 | -$3.48 M | - | - |
FAQ
- What is Aptose Biosciences annual operaing income?
- What is the all time high annual operating profit for Aptose Biosciences?
- What is Aptose Biosciences annual operating profit year-on-year change?
- What is Aptose Biosciences quarterly operating income?
- What is the all time high quarterly operating profit for Aptose Biosciences?
- What is Aptose Biosciences quarterly operating profit year-on-year change?
- What is Aptose Biosciences TTM operating income?
- What is the all time high TTM operating profit for Aptose Biosciences?
- What is Aptose Biosciences TTM operating profit year-on-year change?
What is Aptose Biosciences annual operaing income?
The current annual operating profit of APTO is -$52.36 M
What is the all time high annual operating profit for Aptose Biosciences?
Aptose Biosciences all-time high annual operaing income is $13.01 M
What is Aptose Biosciences annual operating profit year-on-year change?
Over the past year, APTO annual operaing income has changed by -$9.75 M (-22.90%)
What is Aptose Biosciences quarterly operating income?
The current quarterly operating profit of APTO is -$6.96 M
What is the all time high quarterly operating profit for Aptose Biosciences?
Aptose Biosciences all-time high quarterly operating income is $4.39 M
What is Aptose Biosciences quarterly operating profit year-on-year change?
Over the past year, APTO quarterly operating income has changed by +$4.72 M (+40.37%)
What is Aptose Biosciences TTM operating income?
The current TTM operating profit of APTO is -$36.20 M
What is the all time high TTM operating profit for Aptose Biosciences?
Aptose Biosciences all-time high TTM operating income is $1.53 M
What is Aptose Biosciences TTM operating profit year-on-year change?
Over the past year, APTO TTM operating income has changed by +$14.44 M (+28.51%)